Literature DB >> 17610413

Leptin in autoimmunity: many questions, some answers.

G Matarese1, E H Leiter, A La Cava.   

Abstract

It has recently become apparent that several molecules involved in the control of metabolism also play an important function in the regulation of immune responses. Among those molecules, the adipocyte-derived cytokine leptin has been shown to significantly influence innate and adaptive immune responses both in normal and in pathological conditions. For example, levels of leptin are typically low in infection and high in autoimmunity, both systemically and at the site of inflammation. Moreover, in addition to its long-known effects on the promotion of T helper 1 immune responses and cell-mediated immunity, leptin has more recently been found capable to constrain proliferation of regulatory T cells. As such, leptin represents not only a link between metabolism and immune responses in general but also a pivotal modulator of the magnitude of selected mechanisms of peripheral immunity in relation to body fat mass. We review here the most recent advances on the role of leptin in the control of immune tolerance and critically discuss how strategies aimed at neutralizing the leptin axis could represent innovative tools for the therapy of autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610413     DOI: 10.1111/j.1399-0039.2007.00886.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  24 in total

1.  Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Fabiana S Machado; Louis M Weiss; Gary J Schwartz; Mahalia S Desruisseaux; Yang Zhao; Stephen M Factor; Huan Huang; Chris Albanese; Mauro M Teixeira; Philipp E Scherer; Streamson C Chua; Herbert B Tanowitz
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  Role of leptin in autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Siloşi; Suzana Rogoz
Journal:  Maedica (Bucur)       Date:  2013-03

3.  Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Respir Med       Date:  2016-10-11       Impact factor: 3.415

Review 4.  What's new in our understanding of the role of adipokines in rheumatic diseases?

Authors:  Rodolfo Gómez; Javier Conde; Morena Scotece; Juan Jesus Gómez-Reino; Francisca Lago; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

5.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.

Authors:  Maria Pini; Melissa E Gove; Joseph A Sennello; Jantine W P M van Baal; Lawrence Chan; Giamila Fantuzzi
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 6.  Three questions about leptin and immunity.

Authors:  Giamila Fantuzzi
Journal:  Brain Behav Immun       Date:  2008-10-25       Impact factor: 7.217

7.  Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.

Authors:  Andrea Stofkova; Blanka Zelezna; Marianna Romzova; Olga Ulicna; Alexander Kiss; Martina Skurlova; Jana Jurcovicova
Journal:  Mediators Inflamm       Date:  2010-09-30       Impact factor: 4.711

8.  Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in Rats.

Authors:  Kathryn L Pepple; Lauren Rotkis; Jennifer Van Grol; Leslie Wilson; Angela Sandt; Deborah L Lam; Eric Carlson; Russell N Van Gelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 9.  Cytokines, leptin, and stress-induced thymic atrophy.

Authors:  Amanda L Gruver; Gregory D Sempowski
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

Review 10.  The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.